Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gynecologic 1

Conditions

Ovarian Neoplasms 152Endometrial Neoplasms 92Uterine Cervical Neoplasms 78Fallopian Tube Neoplasms 42Breast Neoplasms 42Colorectal Neoplasms 36Carcinoma, Non-Small-Cell Lung 31Pancreatic Neoplasms 26Prostatic Neoplasms 23Triple Negative Breast Neoplasms 21Neoplasms 21Neoplasm Metastasis 21Stomach Neoplasms 20Squamous Cell Carcinoma of Head and Neck 17Esophageal Neoplasms 17Urinary Bladder Neoplasms 16Head and Neck Neoplasms 16Carcinoma, Renal Cell 16Carcinoma, Ovarian Epithelial 16Melanoma 15Lung Neoplasms 14Uterine Neoplasms 13Carcinoma, Hepatocellular 13Carcinoma, Transitional Cell 12Sarcoma 11Cholangiocarcinoma 11Vulvar Neoplasms 10Small Cell Lung Carcinoma 10Rectal Neoplasms 10Colonic Neoplasms 10

Interventions

Tirzepatide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hyperplasia × Gynecologic × 30 days × Clear all
NCT07078838 2026-06-04

Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer

UNC Lineberger Comprehensive Cancer Center

Phase 2 Not yet recruiting
40 enrolled
GynecologicOther

Endometrial Hyperplasia, Hyperplasia, Obesity, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡